# EDGAR Filing Document

**Accession Number:** 0001686315
**File Stem:** 0001641172-25-014034
**Filing Date:** 2025-6
**Character Count:** 7380
**Document Hash:** dc206ae60a4dc86e0d07f26c89e4c159
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-014034.hdr.sgml**: 20250606

**ACCESSION NUMBER**: 0001641172-25-014034

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250604

**FILED AS OF DATE**: 20250606

**DATE AS OF CHANGE**: 20250606

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Luzon Ronen
- **CENTRAL INDEX KEY:** 0001686315

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37370
- **FILM NUMBER:** 251030734

**MAIL ADDRESS:**
- **STREET 1:** 3 ARAVA ST. P.O.B 1026
- **CITY:** AIRPORT CITY
- **STATE:** L3
- **ZIP:** 7010000
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** My Size, Inc.
- **CENTRAL INDEX KEY:** 0001211805
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 4 HANEGEV ST,
- **STREET 2:** POB 1026,
- **CITY:** AIRPORT CITY
- **STATE:** L3
- **ZIP:** 7010000
- **BUSINESS PHONE:** 972-36009030

**MAIL ADDRESS:**
- **STREET 1:** 4 HANEGEV ST,
- **STREET 2:** POB 1026,
- **CITY:** AIRPORT CITY
- **STATE:** L3
- **ZIP:** 7010000

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Mysize Inc.
- **DATE OF NAME CHANGE:** 20150317

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TOPSPIN MEDICAL INC
- **DATE OF NAME CHANGE:** 20021226

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Luzon Ronen<br><sub>(Last) (First) (Middle)</sub><br>C/O MY SIZE INC.<br>HANEGEV 4, POB 1026<br><sub>(Street)</sub><br>AIRPORT CITY, L3 7019900<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-04 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>My Size, Inc. [ MYSZ ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Option to purchase Common Stock (right to buy) | $8.72 | 2025-06-04 |  | D |  |  | 800 | <sup>(1)</sup> | 2025-08-10 | Common Stock, $.001 par value per share | 800 | <sup>(2)</sup> | 0 | D |  |
| Option to purchase Common Stock (right to buy) | $1.28 | 2025-06-04 |  | A |  | 800 |  | <sup>(1)</sup> | 2025-08-10 | Common Stock, $.001 par value per share | 800 | <sup>(2)</sup> | 800 | D |  |
| Option to purchase Common Stock (right to buy) | $8.72 | 2025-06-04 |  | D |  |  | 650 | <sup>(1)</sup> | 2025-08-10 | Common Stock, $.001 par value per share | 650 | <sup>(2)</sup> | 0 | I | see footnote<sup>(3)</sup> |
| Option to purchase Common Stock (right to buy) | $1.28 | 2025-06-04 |  | A |  | 650 |  | <sup>(1)</sup> | 2025-08-10 | Common Stock, $.001 par value per share | 650 | <sup>(2)</sup> | 650 | I | see footnote<sup>(3)</sup> |

---

### Footnotes:

(1) Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.

(2) Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged.

(3) Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).

**Remarks:**
On December 8, 2022, the Company implemented a 1-for-25 reverse stock split (the "2022 Reverse Stock Split") of the Company's common stock, and on April 23, 2024, the Company implemented a 1-for-8 reverse stock split (the "2024 Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the 2022 Reverse Stock Split and the 2024 Reverse Stock Split.

**Signature:** /s/ Ronen Luzon  
**Date:** 2025-06-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**